July Newsletter available

The July Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.

Do not hesitate to contact us with comments or suggestions.

DIDB Editorial Team


June Newsletter available

The June Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.

Do not hesitate to contact us with comments or suggestions.

DIDB Editorial Team


DIDB Team to participate in the upcoming DDI Conference, June 20-22 in Seattle

Drs. Jingjing Yu, Sophie Argon, and Savannah McFeely will speak at the upcoming 22nd International Conference on Drug-Drug Interactions, June 20-22, Seattle WA.

Also, visit our exhibit booth during the conference to learn about new developments and upcoming features.


May Newsletter available

The May Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.

Do not hesitate to contact us with comments or suggestions.

DIDB Editorial Team


April Newsletter available

The April Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.

Do not hesitate to contact us with comments or suggestions.

DIDB Editorial Team


Upcoming release of new features on April 6, 2019!

The DIDB Team will release new features on Saturday April 6, 2019. The release includes the following improvements:

  • Revised home page with a new “Latest NDAs entered” section.
  • Added number of entries (studies) to standard citation info.
  • Added new monograph page for all compounds.
    • This new monograph page combines the previously separate PK summary, QT summary, and monograph into a single page.
    • What was formerly known as “Monograph” is now “DDI summary” and has been renamed throughout application.
    • New monograph page also aggregates some other additional information on each compound such as DIDB defined compound relationships, other properties from DIDB, and some selected external resources.
    • Every compound has a monograph page, but many compounds may not have a DDI, PK, or QT summary, so there may be very little information presented.
  • In Resource Center, added listings of all compounds in each therapeutic class, including DDI risk information.  This new therapeutic class information is a replacement for the DDI risk information which was presented in the Disease section.   The entire Disease section has been removed.
  • In Resource Center, added two new listings – all compounds with DDI Summaries and all compounds with PK Profiles.
  • Removed pdf product labels and replaced with link to Drugs@FDA when an NDA is related to the drug.

Do not hesitate to contact us at didbase@uw.edu if you have any feedback or questions!


March Newsletter available

The March Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.

Do not hesitate to contact us with comments or suggestions.

DIDB Editorial Team


February Newsletter available

The February Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.

Do not hesitate to contact us with comments or suggestions.

DIDB Editorial Team